Transrectal high-intensity focused ultrasound for treatment of patients with stage T1b-2n0m0 localized prostate cancer: a preliminary report

By Uchida T.   Sanghvi N.T.   Gardner T.A.   Koch M.O.   Ishii D.   Minei S.   Satoh T.   Hyodo T.   Irie A.   Baba S.  

Urology, Vol. 59, Iss. 3, 2002-03 ,pp. : 394-398

Elsevier

Access to resources Recommend Favorite

Prognostic significance of prostate-specific antigen in stage T1c prostate cancer treated by radical prostatectomy

By Cookson M.S.   Fleshner N.E.   Soloway S.M.   Fair W.R.  

Urology, Vol. 49, Iss. 6, 1997-06 ,pp. : 887-893

Elsevier

Access to resources Recommend Favorite

External beam radiotherapy for stage T1/T2 prostate cancer: how does it stack up?

By Pollack A.   Zagars G.K.  

Urology, Vol. 51, Iss. 2, 1998-02 ,pp. : 258-264

Elsevier

Access to resources Recommend Favorite

Thrombospondin-1 expression in patients with pathologic stage T3 prostate cancer undergoing radical prostatectomy: association with p53 alterations, tumor angiogenesis, and tumor progression

By Grossfeld G.D.   Carroll P.R.   Lindeman N.   Meng M.   Groshen S.   Feng A.-C.   Hawes D.   Cote R.J.  

Urology, Vol. 59, Iss. 1, 2002-01 ,pp. : 97-102

Elsevier

Access to resources Recommend Favorite

Substratification of stage T1C prostate cancer based on the probability of biochemical recurrence

By Gretzer M.B.   Epstein J.I.   Pound C.R.   Walsh P.C.   Partin A.W.  

Urology, Vol. 60, Iss. 6, 2002-12 ,pp. : 1034-1039

Elsevier

Access to resources Recommend Favorite